Implementation of a guideline-based cardiovascular risk assessment and decision aid tool for General Practice (CHAT-GP)
Not Applicable
- Conditions
- Cardiovascular diseaseCardiovascular - Other cardiovascular diseasesPublic Health - Health service research
- Registration Number
- ACTRN12621000583842
- Lead Sponsor
- niversity of Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
To be included in the trial, practices must see, on average, at least 5 patients who are eligible (45-74 years old, or 30-74 if Aboriginal or Torres Strait Islander, and with no diagnosis of cardiovascular disease) to receive a cardiovascular disease risk assessment, weekly.
Practices must also have access to the PEN CS suite of tools, including Topbar, and must allow the research team to have access to their data (related to CVD risk assessments) for 6 months.
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is complete absolute CVD risk assessment data for eligible (45-74 years, 30-74 if Aboriginal or Torres Strait Islander, old, with no diagnosis of cardiovascular disease) patients seen in the last month, assessed via monthly Pen CS reports from participating GP practices. [Monthly assessment for the 6 month duration of the study of all groups in the stepped wedge trial (both control and intervention). ]
- Secondary Outcome Measures
Name Time Method Secondary outcomes will include guidelines-based management (medication prescribed for high risk and not low risk patients) as indicated in Pen CS reports, <br><br>[End of trial (6 months post-enrolment)];GP referral to the My Health For Life lifestyle program based on standard data collected by partner organisation the National Heart Foundation (for Queensland sites only).[End of trial (6 months post enrolment)]